Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Johnson and Johnson under FBI scanner over possibilities of surgical device power morcellator spread

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Philips Elevate Plus Gains FDA Clearance...

Philips announced that it has obtained FDA clearance for...

Smith+Nephew Launches Next-Generation LEAF Platform for...

Smith+Nephew has announced the launch of its next-generation LEAF...

$2.4bn I-MED Radiology Network Acquisition by...

Jardine Matheson has entered into an agreement to purchase...

The FBI is investigating whether Johnson and Johnson was aware that a surgical device it manufactured could spread cancer in the women on whom it is used.
The FBI is investigating whether Johnson and Johnson was aware that a surgical device it manufactured could spread cancer in the women on whom it is used.
Johnson and Johnson is one of the leading manufacturers of the power morcellator — a surgical device that breaks down growths in the uterus so that they can be easily removed. However, in as many as one out of every 350 cases, an unknown cancer is hidden within growths, and the device could potentially worsen the condition.
Johnson and Johnson may have been alerted to to the risks as early as 2006. The company didn’t remove the device from the market, however, until July 2014. In November of that year, the U.S. Food and Drug Administration implemented its most serious warning on the device.
In that FDA warning, the agency noted that the device could “significantly [worsen] the patient’s long-term survival.”
The agency urged against the use of power morcellators.

 

Never miss a healthcare headline

Healthcare moves fast โ€“ stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management
MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Philips Elevate Plus Gains FDA Clearance for AI Ultrasound

Philips announced that it has obtained FDA clearance for...

Smith+Nephew Launches Next-Generation LEAF Platform for Remote Patient Monitoring

Smith+Nephew has announced the launch of its next-generation LEAF...

$2.4bn I-MED Radiology Network Acquisition by Jardine Matheson

Jardine Matheson has entered into an agreement to purchase...

Olympus Acquires BioProtect to Expand Oncology and Urology Provision

Olympus has finalized an agreement to acquire Israel-based BioProtect...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป